Matrix Capital Management Company, LP - 30 Nov 2024 SCHEDULE 13G/A Report for Adaptimmune Therapeutics PLC Ordinary Shares, par value 0.001 GBP per share (ADAP)

Filing Manager: Matrix Capital Management Company, LP
Reporting Manager: Matrix Capital Management Company LP
Security: Adaptimmune Therapeutics PLC Ordinary Shares, par value 0.001 GBP per share
Symbol: ADAP
Shares outstanding: 1,534,090,909 shares
Disclosed Ownership: 135,000,000 shares
Ownership: 8.8%
Form type: SCHEDULE 13G/A
Filing time: 05 Dec 2024, 17:17:56 UTC
Date of event: 30 Nov 2024
Next filing: 08 Jan 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Matrix Capital Management Company LP	8.8%	135,000,000	0	135,000,000	/s/ David E. Goel	David E. Goel, Managing General Partner
David E. Goel	8.8%	135,000,000	0	135,000,000	/s/ David E. Goel	David E. Goel, individually